Sherwin-Williams
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Sherwin-Williams's revenues will increase 5.7% and EPS will expand 32.2%.
The average estimate for revenue is $2.19 billion. On the bottom line, the average EPS estimate is $1.15.
Revenue details
Last quarter, Sherwin-Williams logged revenue of $2.60 billion. GAAP reported sales were 4.8% higher than the prior-year quarter's $2.48 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, EPS came in at $2.24. GAAP EPS of $2.24 for Q3 were 31% higher than the prior-year quarter's $1.71 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 44.2%, 240 basis points better than the prior-year quarter. Operating margin was 13.4%, 230 basis points better than the prior-year quarter. Net margin was 9.0%, 180 basis points better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $9.51 billion. The average EPS estimate is $6.51.
Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 440 members out of 491 rating the stock outperform, and 51 members rating it underperform. Among 203 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 190 give Sherwin-Williams a green thumbs-up, and 13 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Sherwin-Williams is hold, with an average price target of $140.07.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Sherwin-Williams to My Watchlist.